Coalition letter to Governor Hochul: S3081B is anti-taxpayer, anti-patient, and anti-free market BySteve Pociask December 20, 2022December 20, 2022
ACI Files Comments with the FTC Regarding PBM Business Practices and their Impact on Drug Prices BySteve Pociask April 20, 2022April 20, 2022
Coalition Tells Congress: Say “No” to Price Controls ByKrisztina Pusok November 17, 2021November 17, 2021
Generics and Biosimilars are the Keys to Lower Drug Prices ByEdward Longe October 15, 2021June 3, 2022
ACI Sends a Letter to Congress on Reducing Patient Drug Prices BySteve Pociask September 10, 2021September 10, 2021
ACI Joins Coalition Letter in Support of Biosimilar Competition BySteve Pociask July 1, 2021July 1, 2021
Town Hall: Level the Playing Field for Drug Companies and Patients ByFoday Turay June 29, 2021June 29, 2021
